- Conditions
- Breast Neoplasm
- Interventions
- Ultrasound, 0.25% bupivacaine
- Device · Drug
- Lead sponsor
- Huntington Memorial Hospital
- Other
- Eligibility
- 18 Years to 85 Years · Female only
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 1
- States / cities
- Pasadena, California
Source: ClinicalTrials.gov public record
Updated Sep 22, 2016 · Synced May 22, 2026, 5:05 AM EDT